Your session is about to expire
← Back to Search
Ablation for Atrial Flutter
Study Summary
This trial will evaluate the safety, feasibility, and efficacy of performing atrial flutter ablation through the arm vs. the standard femoral vein approach. #MedicalStudy #AtrialFlutter
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently admitted to a hospital.You have a pacemaker or defibrillator with certain types of leads.I am scheduled for a procedure to correct heart flutter as an outpatient.You have a specific heart rhythm problem called atrial flutter, which has been confirmed by a heart test called EKG or telemetry.I weigh at least 110 pounds.My body weight is under 50 Kg.I am unable to give consent by myself.
- Group 1: Ablation through upper extremity
- Group 2: Ablation through femoral vein
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are currently participating in this clinical experiment?
"Affirmative, the information on clinicaltrials.gov affirms that this trial is still recruiting participants. The study was first posted on October 28th 2021 and has most recently been updated in March 2nd 2023. Presently, 40 volunteers must be sourced from 1 medical centre."
Are participants currently being enrolled in this experiment?
"Correct. Clinicaltrials.gov reveals that this clinical trial is still enlisting participants; initial posting was on October 28th 2021 and the information has been updated as recently as March 2nd 2023. The study requires 40 patients from a single site to complete its enrolment goals."
Share this study with friends
Copy Link
Messenger